You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ocular Hypertension (OHT)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye Trial

Not yet recruiting
  • Primary Open Angle Glaucoma (POAG)
  • +3 more
  • Experimental: QLS-111 ophthalmic solution, (0.015%)
  • +4 more
  • (no location specified)
Aug 30, 2023

Open Angle Glaucoma, Ocular Hypertension Trial in United States (OTX-TIC low dose Travoprost Intracameral Implant, OTX-TIC high

Recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • OTX-TIC low dose Travoprost Intracameral Implant
  • +2 more
  • Delray Beach, Florida
  • +8 more
Apr 12, 2022

Vivity in Patients With Well Controlled Glaucoma

Recruiting
  • Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
  • Vivity Extended Depth of Focus
  • Montréal, Quebec, Canada
    Clinique Bellevue
Sep 29, 2021

Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost SR, LUMIGAN)

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Dothan, Alabama
  • +5 more
May 17, 2022

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Setagaya-Ku (Netarsudil ophthalmic solution 0.02%, Ripasudil HCl

Completed
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • Netarsudil ophthalmic solution 0.02%
  • Ripasudil hydrochloride hydrate ophthalmic solution 0.4%
  • Setagaya-Ku, Tokyo, Japan
    Seijo Clinic
Aug 29, 2021

OAG - Open-Angle Glaucoma, OHT - Ocular Hypertension Trial (Netarsudil 0.02% QD, Timolol maleate 0.5% BID)

Withdrawn
  • OAG - Open-Angle Glaucoma
  • OHT - Ocular Hypertension
  • Netarsudil 0.02% QD
  • Timolol maleate 0.5% BID
  • (no location specified)
Mar 17, 2022

Glaucoma, OHT - Ocular Hypertension Trial in Rochester, Omaha, Columbus (Timolol 0.5% ophthalmic solution, Latanoprost 0.005%

Recruiting
  • Glaucoma
  • OHT - Ocular Hypertension
  • Timolol 0.5% ophthalmic solution
  • Latanoprost 0.005% Ophthalmic Solution
  • Rochester, Minnesota
  • +2 more
Jul 15, 2022

Impact of Self-tonometry on Glaucoma Treatment Decision.

Completed
  • Glaucoma
  • +3 more
  • Unchanged treatment
  • Changed treatment
  • Stockholm, Sweden
    St Erik Eye Hospital
Mar 1, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Travoprost, Placebo Vehicle)

Completed
Has Results
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Sep 14, 2021

Preservative-free Fixed-dose Combination of Tafluprost 0.0015% /

Completed
  • Ocular Surface Disease
  • Primary Open Angle Glaucoma
  • Tafluprost, timolol maleate
  • Taoyuan city, Taiwan
    Chang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospita
Oct 27, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in Te Aro, Rotorua (100ng/day PA5346 Latanoprost FA SR Ocular Implant)

Recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • 100ng/day PA5346 Latanoprost FA SR Ocular Implant
  • Te Aro, Wellington, New Zealand
  • +1 more
Apr 10, 2022

OAG - Open-Angle Glaucoma, OHT - Ocular Hypertension Trial in La Jolla (Latanoprostene bunod 0.024% QD, Timolol maleate 0.5%

Completed
  • OAG - Open-Angle Glaucoma
  • OHT - Ocular Hypertension
  • Latanoprostene bunod 0.024% QD
  • Timolol maleate 0.5% BID
  • La Jolla, California
    UCSD Shiley Eye Institute
Jul 2, 2021

Ocular Hypertension, Primary Open Angle Glaucoma Trial in United States (Latanoprost ophthalmic solution, AKB-9778, Placebo)

Completed
  • Ocular Hypertension
  • Primary Open Angle Glaucoma
  • Latanoprost ophthalmic solution
  • +2 more
  • Inglewood, California
  • +20 more
Jan 13, 2021

Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Travoprost Ophthalmic Topical Cream low-dose, Travoprost

Not yet recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Travoprost Ophthalmic Topical Cream low-dose
  • +4 more
  • Newport Beach, California
    Glaukos Clinical Study Site
Nov 22, 2023

Glaucoma, Primary Open Angle, Ocular Hypertension Trial in Newport Beach (Study Treatment 1 WB007, Study Treatment 2 WB007,

Active, not recruiting
  • Glaucoma, Primary Open Angle
  • Ocular Hypertension
  • Study Treatment 1 WB007
  • +3 more
  • Newport Beach, California
    Eye Research Foundation
Dec 30, 2022

Ocular Hypertension Trial in Rochester (Latanoprostene Bunod, Placebo)

Recruiting
  • Ocular Hypertension
  • Latanoprostene Bunod
  • Placebo
  • Rochester, Minnesota
    Bausch Site 001
Sep 29, 2022

Ocular Hypertension Trial in Australia (FM101 tablet, FM101 oral solution, Placebo)

Recruiting
  • Ocular Hypertension
  • FM101 tablet
  • +4 more
  • Bella Vista, New South Wales, Australia
  • +4 more
Jul 18, 2022

Open-Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Nebivolol Ophthalmic Suspension 1 Percent, Nebivolol Ophthalmic

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Nebivolol Ophthalmic Suspension 1 Percent
  • +3 more
  • Newport Beach, California
    Site 0012
Jul 18, 2022

Glaucoma, Glaucoma, Open-Angle, Glaucoma, Primary Open Angle Trial in Madurai, Pondicherry (Nanodropper adaptor, Original

Recruiting
  • Glaucoma
  • +4 more
  • Nanodropper adaptor
  • Original eyedrop bottle/No Nanodropper
  • Madurai, India
  • +1 more
Jan 4, 2022

POAG Trial (Eagle)

Not yet recruiting
  • POAG
  • Eagle
  • (no location specified)
Jun 5, 2023

Ocular Hypertension, Primary Open Angle Glaucoma Trial in Lackland Air Force Base (Nanodropper, Regular dropper)

Recruiting
  • Ocular Hypertension
  • Primary Open Angle Glaucoma
  • Nanodropper
  • Regular dropper
  • Lackland Air Force Base, Texas
    Wilford Hall Ambulatory Surgical Center
May 3, 2023

Sturge-Weber Syndrome, Glaucoma, Ocular Hypertension Trial (QLS-101 ophthalmic solution, 2.0 %)

Not yet recruiting
  • Sturge-Weber Syndrome
  • +2 more
  • QLS-101 ophthalmic solution, 2.0 %
  • (no location specified)
Aug 8, 2022

Glaucoma Open-Angle Primary, Ocular Hypertension Trial in Albany (H-1337 0.6%, H-1337 1.0%, H-1337 Placebo)

Not yet recruiting
  • Glaucoma Open-Angle Primary
  • Ocular Hypertension
  • H-1337 0.6%
  • +3 more
  • Albany, Georgia
    Dixon Eye Care
Jun 12, 2023

Open Angle Glaucoma, Ocular Hypertension Trial in Yerevan (iDose TR)

Recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • iDose TR
  • Yerevan, Armenia
    Glaukos Clinical Study Site
Sep 25, 2023

Glaucoma, Open-Angle, Hypertension, Ocular Trial in Austin (NCX 470, Latanoprost 0.005%)

Completed
Has Results
  • Glaucoma, Open-Angle
  • Hypertension, Ocular
  • NCX 470
  • Latanoprost 0.005%
  • Austin, Texas
    Texan Eye
Nov 9, 2022